t74616a_defa14a.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 14A
 
Proxy Statement pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.    )
 
Filed by the Registrant  þ                            
Filed by a Party other than the Registrant  o
 
Check the appropriate box:
 
o
Preliminary Proxy Statement
   
o
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
   
o
Definitive Proxy Statement
   
þ
Definitive Additional Materials
   
o
Soliciting Material Pursuant to §240.14a-12
 
GREENWAY MEDICAL TECHNOLOGIES, INC.
(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
   
þ
No fee required.
   
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
     
 
1)
 
Title of each class of securities to which transaction applies:
 
 
2)
 
Aggregate number of securities to which transaction applies:
 
 
3)
 
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
 
4)
 
Proposed maximum aggregate value of transaction:
 
 
5)
 
Total fee paid:
       
   
o
Fee paid previously with preliminary materials.
   
o
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
     
 
1)
 
Amount Previously Paid:
 
 
2)
 
Form, Schedule or Registration Statement No.:
 
 
3)
 
Filing Party:
 
 
4)
 
Date Filed:
 
 
 
 

 
 
*** Exercise Your Right to Vote ***
 
Important Notice Regarding the Availability of Proxy Materials for the
 
Shareholder Meeting to Be Held on  November 07, 2012
 
   
           
     
Meeting Information
GREENWAY MEDICAL TECHNOLOGIES, INC.  
Meeting Type: Annual Meeting
For holders as of: September 12, 2012
     
Date: November 07, 2012       Time: 11:30 AM EST
 
 
 
 
 
 
 
 
 
GREENWAY MEDICAL TECHNOLOGIES, INC
121 GREENWAY BOULEVARD
CARROLLTON, GA 30117
 
Location:  
Greenway Headquarters
121 Greenway Boulevard
Carrollton, GA 30117
   
 
     
     
     
 
You are receiving this communication because you hold shares in the above named company.
 
This is not a ballot.  You cannot use this notice to vote these shares.  This communication presents only an overview of the more complete proxy materials that are available to you on the Internet.  You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
 
We encourage you to access and review all of the important information contained in the proxy materials before voting.
 
 
See the reverse side of this notice to obtain proxy materials and voting instructions.
 
 
0000150213_1     R1.0.0.11699
 
 
 

 
 
—— Before You Vote ——
How to Access the Proxy Materials
   
Proxy Materials Available to VIEW or RECEIVE:
 
   
1. Form 10-K          2. Notice & Proxy Statement          3. Annual Report
 
   
How to View Online:
 
   
Have the information that is printed in the box marked by the arrow    Ú
XXXX XXXX XXXX
  (located on the following page) and visit:
 
    www.proxyvote.com.      
   
How to Request and Receive a PAPER or E-MAIL Copy:
 
   
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
     
1) BY INTERNET:
www.proxyvote.com
 
     
2) BY TELEPHONE:    
1-800-579-1639
 
     
3) BY E-MAIL*:
sendmaterial@proxyvote.com
 
   
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the
 
    arrow  Ú  XXXX XXXX XXXX   (located on the following page) in the subject line.  
   
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before October 24, 2012 to facilitate timely delivery.
       
 
—— How To Vote ——
Please Choose One of the Following Voting Methods
             
   
Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.  At the meeting, you will need to request a ballot to vote these shares.
     
         
    Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the    
    arrow Ú  XXXX XXXX XXXX   available and follow the instructions.    
   
 
    
   
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
 
       
         
 
0000150213_2     R1.0.0.11699
 
 
 

 
 
               
Voting items
       
The Board of Directors recommends you vote
FOR all of the listed nominees:
 
1.
 
Election of Directors
 
01
Nominees
Thomas T. Richards
 
02 
 
Walter Turek
 
The Board of Directors recommends you vote FOR the following proposal:
 
2.
Ratification of the selection of Grant Thornton LLP as independent registered public accountants for the year
ending June 30, 2013.
 
NOTE: The proxies will vote in their discretion regarding such other business as may properly come before the
meeting or any adjournment thereof.
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
0000150213_3     R1.0.0.11699
 
 
 

 
 
           
 
 
       
           
           
           
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
0000150213_4     R1.0.0.11699